| 发明名称 |
Therapeutic Agents and Uses Thereof |
| 摘要 |
The present application provides an agent comprising or consisting of a binding moiety with specificity for a kallikrein protein (for example, PSA or hK2) for use in the treatment of prostate cancer, and a method for the treatment of prostate cancer in a patient, the method comprising the step of administering a therapeutically effective amount of an agent comprising or consisting of a binding moiety with specificity for a kallikrein protein to the patient. |
| 申请公布号 |
US2016317683(A1) |
申请公布日期 |
2016.11.03 |
| 申请号 |
US201615135028 |
申请日期 |
2016.04.21 |
| 申请人 |
FredAx AB |
发明人 |
Strand Sven-Erik;Tran Amanda Thuy;Axelsson Sven-Niklas Anders |
| 分类号 |
A61K51/10;C07K16/40;C07K16/30 |
主分类号 |
A61K51/10 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1: An agent comprising (a) an antibody or antigen-binding fragment thereof with specificity for a kallikrein protein and (b) a cytotoxic moiety. |
| 地址 |
Helsingborg SE |
